home / stock / syrs / syrs news


SYRS News and Press, Syros Pharmaceuticals Inc. From 08/05/21

Stock Information

Company Name: Syros Pharmaceuticals Inc.
Stock Symbol: SYRS
Market: NASDAQ
Website: syros.com

Menu

SYRS SYRS Quote SYRS Short SYRS News SYRS Articles SYRS Message Board
Get SYRS Alerts

News, Short Squeeze, Breakout and More Instantly...

SYRS - TRVN, PIXY and OBLG among pre market gainers

Score Media and Gaming (NASDAQ:SCR) +65% Penn National Gaming inks deal to acquire Score Media and Gaming Ensysce Biosciences (NASDAQ:ENSC) +38% announces notice of allowance from the U.S. Patent and trademark office for Patent entitled “compositions comprising enzyme-cl...

SYRS - Syros Reports Second Quarter 2021 Financial Results and Highlights Key Accomplishments and Upcoming Milestones

Today Announced Agreement with Roche to Evaluate SY-5609 in Combination with Immunotherapy in BRAF-Mutant Colorectal Cancer Patients Additional Dose Escalation Data for SY-5609 to be Highlighted in Oral Presentation at ESMO Congress; On Track to Advance into Phase 1 Expansion ...

SYRS - Syros Announces Agreement with Roche to Evaluate SY-5609 as Part of a Novel Combination for Treatment of Colorectal Cancer

Clinical Trial Cohort to Evaluate SY-5609 in Combination with Atezolizumab, a PD-L1 Checkpoint Inhibitor Marks First Clinical Investigation of Selective CDK7 Inhibitor with Immunotherapy Syros Pharmaceuticals (NASDAQ:SYRS), a leader in the development of medicines th...

SYRS - Syros to Report Second Quarter 2021 Financial Results on Thursday, August 5, 2021

Syros Pharmaceuticals (NASDAQ:SYRS), a leader in the development of medicines that control the expression of genes, today announced that it will host a live conference call and webcast at 8:30 a.m. ET on Thursday, August 5, 2021 to report its second quarter 2021 financial results and pr...

SYRS - Syros Pharmaceuticals Inc.: New 52-Week Low Set Today (SYRS)

Shares of Syros Pharmaceuticals Inc. (NASDAQ:SYRS) traded today at $4.44, breaking its 52-week low. So far today approximately 771,000 shares have been exchanged, as compared to an average 30-day volume of 1.2 million shares. In the past 52 weeks, Syros Pharmaceuticals Inc. share prices ...

SYRS - Syros: Pivotal Trial In MDS Ongoing

SYRS has a pivotal trial in MDS going on, with data next year. Their pipeline is varied, with multiple shots on goal. The cash position is also strong. For further details see: Syros: Pivotal Trial In MDS Ongoing

SYRS - 9 Hot Penny Stocks To Watch Right Now, Analyst Targets Up To 290%

Analysts Are Boosting Ratings & Targets For These Current & Former Penny Stocks Penny stocks can be some of the most exciting types of stocks in the market. Few other asset classes offer such potential to see significant returns in such a short period of time. Now, by definition...

SYRS - Syros Pharmaceuticals to Present at JMP Securities 2021 Life Sciences Conference

Syros Pharmaceuticals (NASDAQ:SYRS), a leader in the development of medicines that control the expression of genes, today announced that its Chief Executive Officer, Nancy Simonian, M.D., will participate in a fireside chat at the JMP Securities 2021 Life Sciences Conference. Details ar...

SYRS - 7 Best Penny Stocks to Buy for Your June Buy List

InvestorPlace - Stock Market News, Stock Advice & Trading Tips You don’t need a financial expert or anyone of any credentials to tell you why penny stocks are so appealing. That’s akin to explaining how the dazzling lights and sounds of Las Vegas might lure in tourists fr...

SYRS - BB, AMC, CLDR and BTU among notable premarket gainers

Vertex Energy (VTNR) +28%.Cloudera CLDR +24% on being acquired by Clayton, Dubilier & Rice and KKR for $5.3 billion.Orbsat Corp Common Stock (OSAT) +19%.AMC Entertainment Holdings AMC +16% on raising $230.0 million.Lineage Cell Therapeutics LCTX +14% on updat...

Previous 10 Next 10